Skip to Content

Tag: neurostimulation device


Also Noted

Inspire names former Medtronic exec as chief strategy officer 

July 24, 2023HME News Staff

MINNEAPOLIS – Inspire Medical Systems, the maker of an FDA-approved neurostimulation device to treat obstructive sleep apnea, has appointed Carlton Weatherby as chief strategy officer effective July 24. “We are very excited to welcome Carlton to the Inspire team,” said Tim Herbert, president and CEO of Inspire Medical Systems. “Carlton’s vast experience in leadership roles across medtech, as well as his strategic vision, will be very valuable to us as we continue to...

Carlton Weatherby, Inspire Medical Systems, neurostimulation device, Sleep Therapy


Read Full Articlered right arrow icon

Also Noted

Inspire Medical sees significant growth in Q4 

January 10, 2023HME News Staff

MINNEAPOLIS – Inspire Medical, the maker of an FDA-approved neurostimulation device to treat obstructive sleep apnea, expects revenue of $137.5 million to $137.9 million for the fourth quarter of 2022, about a 76% increase year over year. It expects revenue for the full year to be $407.5 million to $407.9 million, about a 75% increase compared to 2021. “We are very pleased with our strong preliminary revenue performance in the fourth quarter primarily driven by higher utilization at existing...

CPAP Alternative, Inspire Medical, neurostimulation device, Obstructive Sleep Apnea (OSA)


Read Full Articlered right arrow icon